Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono

This page shows the latest Merck Serono news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

Teva’s Copaxone, Biogen’s Avonex and Merck Serono’s Rebif have all been accepted for routine use on the NHS after the companies agreed to lower their prices – in addition

Latest news

More from news
Approximately 23 fully matching, plus 169 partially matching documents found.

Latest Intelligence

  • A rare opportunity A rare opportunity

    The disappearance of that opportunity combined with changes at Merck following its 10.6bn acquisition of Serono gave Neil the momentum to set up his own consultancy business in 2007. ... He worked for a number of pharma clients, including Eisai and Merck

  • Sustainable solutions Sustainable solutions

    Over the summer Alex was appointed chair of the EMG, taking over from Merck' Serono's David Garmon-Jones, and he says both the EMG and its wider, UK industry counterpart ... In May 2014 it paid $14.2bn for Merck &Co's consumer health unit.

  • Deal Watch October 2015 Deal Watch October 2015

    This month's deal between Merck Serono (Merck KGaA) and BioMarin is a good example of this approach. ... Acquisition - company. 580. Merck Serono/ BioMarin. Kuvan and pegvaliase (Kuvan marketed; pegvaliase p3).

  • A bright future for OTC and Merck Consumer Health A bright future for OTC and Merck Consumer Health

    A bright future for OTC and Merck Consumer Health. It's an exciting time for the OTC sector. ... For Merck's Consumer Health business, change and growth in operations has also been driven by the incorporation of new brands, transferred from Merck Serono.

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    Phase 3 immuno-oncology treatment for prostate cancer. 975. Intrexon / Merck Serono.

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics